Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment

Completed · Not applicable

Conditions studied: Gastrointestinal Cancer, Neuroendocrine Carcinoma, Skin Cancer

In brief

This single-blind, randomized controlled trial studies how well inhaled essential oils work for common quality of life concerns in patients who are undergoing cancer treatment such as chemotherapy, targeted therapy, and/or immunotherapy given through the vein (intravenously). Aromatherapy using essential oils, such as ginger essential oil, German chamomile essential oil, and bergamot essential oil, may improve quality of life issues such as nausea, anxiety, loss of appetite, and fatigue in patients undergoing treatment for cancer.

Key facts

Study ID

NCT03858855

Run by

Ohio State University Comprehensive Cancer Center

People needed

248

Starts

2019-02-18

Expected to finish

2020-04-13

Last updated by the study team

2020-08-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Gastrointestinal cancers, neuroendocrine cancer, or melanoma or other skin cancers
• Receiving chemotherapy, targeted therapy, and/or immunotherapy
• Not naive to the treatment
• Must be able to read and write English

You may not qualify if…

• Allergies to ragweed, chrysanthemum, chamomile, ginger, bergamot, citrus fruits, tree nuts, perfumes
• Asthma diagnosis
• Patients receiving only octreotide injections
• Patients receiving floxuridine (FUDR) via hepatic artery infusion (HAI) pump only

Where it is running

• Ohio State University Comprehensive Cancer Center — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.